Venous Thromboembolism in Pregnancy: Challenges and Solutions

Abstract Venous thromboembolism (VTE) is a serious medical condition that can lead to severe morbidity and mortality, making it a significant public health concern. VTE is a multifactorial condition that results from the interaction of genetic, acquired, and environmental factors. Physiological changes during pregnancy increase the risk of VTE as they express Virchow’s triad (increased coagulation factors, decreased fibrinolysis, trauma, and venous stasis). Moreover, pregnancy-related risk factors, such as advanced maternal age, obesity, multiple gestations, and cesarean delivery, further increase the risk of VTE. Managing VTE in pregnancy is challenging due to the complexity of balancing the risks and benefits of anticoagulant therapy for both the mother and the fetus. A multidisciplinary approach involving obstetricians, hematologists, and neonatologists, is necessary to ensure optimal outcomes for both the mother and baby. This review aims to discuss the current challenges associated with VTE in pregnancy and identify potential solutions for improving outcomes for pregnant women at risk for VTE.

[1]  Bethany Samuelson Bannow,et al.  Multidisciplinary Care of the Pregnant Patient with or At Risk for VTE: a Recommended Toolkit from the FWGBD Thrombosis Subcommittee. , 2023, Journal of thrombosis and haemostasis : JTH.

[2]  S. Mountantonakis,et al.  Clinical significance of unexplained persistent sinus tachycardia in women with structurally normal heart during the peripartum period , 2022, BMC Pregnancy and Childbirth.

[3]  A. Caughey,et al.  Venous Thromboembolism During Pregnancy and the Postpartum Period: Risk Factors, Diagnostic Testing, and Treatment , 2022, Obstetrical & gynecological survey.

[4]  D. Kalaitzopoulos,et al.  Management of venous thromboembolism in pregnancy. , 2022, Thrombosis research.

[5]  J. Twisk,et al.  Multi-organ point-of-care ultrasound for detection of pulmonary embolism in critically ill COVID-19 patients – A diagnostic accuracy study , 2022, Journal of Critical Care.

[6]  B. Galen,et al.  The Use of Point-of-Care Ultrasound (POCUS) in the Diagnosis of Deep Vein Thrombosis , 2021, Journal of clinical medicine.

[7]  C. Baston,et al.  How I Do It: Point-of-Care Ultrasound for Bedside Diagnosis of Lower Extremity Deep Venous Thrombosis. , 2021, Chest.

[8]  C. Combescure,et al.  D‐dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta‐analysis , 2021, Journal of thrombosis and haemostasis : JTH.

[9]  C. Dennie,et al.  Canadian Society of Thoracic Radiology/Canadian Association of Radiologists Best Practice Guidance for Investigation of Acute Pulmonary Embolism, Part 1: Acquisition and Safety Considerations , 2021, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[10]  P. Middleton,et al.  Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. , 2021, The Cochrane database of systematic reviews.

[11]  I. A. Taranenko,et al.  Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity , 2020, Thrombosis Journal.

[12]  M. Forgie,et al.  Pulmonary embolism: update on management and controversies , 2020, BMJ.

[13]  L. Nayak,et al.  Estrogen and thrombosis: A bench to bedside review. , 2020, Thrombosis research.

[14]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[15]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[16]  N. Montenegro,et al.  Thrombolysis in pregnancy: a literature review , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[17]  W. Callaghan,et al.  Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. , 2019, Seminars in perinatology.

[18]  C. Tromeur,et al.  Pregnancy‐Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism , 2019, The New England journal of medicine.

[19]  B. Rochwerg,et al.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. , 2018, Blood advances.

[20]  A. Kaimal,et al.  ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. , 2018, Obstetrics and gynecology.

[21]  N. Silverman,et al.  ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy. , 2018, Obstetrics and gynecology.

[22]  G. Fuller,et al.  The DiPEP study: an observational study of the diagnostic accuracy of clinical assessment, D‐dimer and chest x‐ray for suspected pulmonary embolism in pregnancy and postpartum , 2018, BJOG : an international journal of obstetrics and gynaecology.

[23]  F. Boehlen,et al.  Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review , 2017, Journal of thrombosis and haemostasis : JTH.

[24]  G. Fuller,et al.  Consensus-derived clinical decision rules to guide advanced imaging decisions for pulmonary embolism in pregnancy and the postpartum period. , 2017, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[25]  R. Rosovsky,et al.  Multidisciplinary pulmonary embolism response teams and systems. , 2016, Cardiovascular diagnosis and therapy.

[26]  M. Huisman,et al.  Accurate diagnosis of iliac vein thrombosis in pregnancy with magnetic resonance direct thrombus imaging (MRDTI) , 2016, BMJ Case Reports.

[27]  A. Davies,et al.  Inferior Vena Cava Filters in Pregnancy: A Systematic Review. , 2016, Journal of vascular and interventional radiology : JVIR.

[28]  Alexandre Mebazaa,et al.  Physiological changes in pregnancy , 2007 .

[29]  M. Rodger,et al.  Guidance for the treatment and prevention of obstetric-associated venous thromboembolism , 2016, Journal of Thrombosis and Thrombolysis.

[30]  N. Maniadakis,et al.  A systematic review and meta‐analysis of the epidemiology and burden of venous thromboembolism among pregnant women , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[31]  S. Lulaj,et al.  Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy , 2015, Journal of human reproductive sciences.

[32]  R. Hicks,et al.  Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France , 2015, The Journal of Nuclear Medicine.

[33]  R. Staff,et al.  Planar and SPECT ventilation/perfusion imaging and computed tomography for the diagnosis of pulmonary embolism: A systematic review and meta-analysis of the literature, and cost and dose comparison. , 2015, European journal of radiology.

[34]  Connie M. Rhee,et al.  A review: Radiographic iodinated contrast media-induced thyroid dysfunction. , 2015, The Journal of clinical endocrinology and metabolism.

[35]  F. Boehlen,et al.  Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population‐based, case‐control study , 2014, Journal of thrombosis and haemostasis : JTH.

[36]  J. Rutherford,et al.  Cardiovascular physiology of pregnancy. , 2014, Circulation.

[37]  J. Damilakis,et al.  Perfusion Scintigraphy Versus 256-Slice CT Angiography in Pregnant Patients Suspected of Pulmonary Embolism: Comparison of Radiation Risks , 2014, The Journal of Nuclear Medicine.

[38]  M. Supanich,et al.  Detection of pulmonary embolism during pregnancy: comparing radiation doses of CTPA and pulmonary scintigraphy , 2014, Nuclear medicine communications.

[39]  C. Combescure,et al.  Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis , 2014, European heart journal.

[40]  L. Magee,et al.  Venous thromboembolism and antithrombotic therapy in pregnancy. , 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[41]  W. Sappenfield,et al.  Pregnancy-Related Deaths Due to Pulmonary Embolism: Findings from Two State-Based Mortality Reviews , 2013, Maternal and Child Health Journal.

[42]  J. West,et al.  Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. , 2013, Blood.

[43]  J. Douketis,et al.  Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging , 2013, Canadian Medical Association Journal.

[44]  F. Rosendaal,et al.  Candidate gene polymorphisms and the risk for pregnancy‐related venous thrombosis , 2012, British journal of haematology.

[45]  J. Alijotas-Reig,et al.  The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A preliminary first year report , 2012, Lupus.

[46]  D. Veenstra,et al.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[47]  J. West,et al.  Risk of first venous thromboembolism in and around pregnancy: a population‐based cohort study , 2012, British journal of haematology.

[48]  G. Dekker,et al.  Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.

[49]  Shalini Jain Bagaria,et al.  Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy , 2011, Journal of pregnancy.

[50]  J. Kline,et al.  Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association , 2011, Circulation.

[51]  M. Eriksson,et al.  Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy. , 2011, Thrombosis research.

[52]  Patrick D. Thornton,et al.  Coagulation in pregnancy. , 2010, Best practice & research. Clinical obstetrics & gynaecology.

[53]  J. Morris,et al.  Incidence and risk factors for pulmonary embolism in the postpartum period , 2010, Journal of thrombosis and haemostasis : JTH.

[54]  M. Rodger,et al.  D‐dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis , 2010, Journal of thrombosis and haemostasis : JTH.

[55]  F. Spencer,et al.  Anatomic distribution of deep vein thrombosis in pregnancy , 2010, Canadian Medical Association Journal.

[56]  S. Krzyzaniak.  Predicting Deep Venous Thrombosis in Pregnancy: Out in “Left” Field? , 2010 .

[57]  M. Rodger,et al.  Predicting Deep Venous Thrombosis in Pregnancy: Out in LEFt Field? , 2009, Annals of Internal Medicine.

[58]  B. Brenner,et al.  Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications , 2009, Journal of thrombosis and haemostasis : JTH.

[59]  M. Makris.  Thrombophilia: grading the risk. , 2009, Blood.

[60]  S. Heath,et al.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.

[61]  D. T. Raa,et al.  Treatment options in massive pulmonary embolism during pregnancy; a case-report and review of literature. , 2009, Thrombosis research.

[62]  F. Rosendaal,et al.  The value of family history as a risk indicator for venous thrombosis. , 2009, Archives of internal medicine.

[63]  P. Gibson,et al.  Anticoagulants and pregnancy: When are they safe? , 2009, Cleveland Clinic Journal of Medicine.

[64]  M. Damodaram,et al.  D-dimers as a screening test for venous thromboembolism in pregnancy: Is it of any use? , 2009, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[65]  E. Myers,et al.  A national study of the complications of lupus in pregnancy. , 2008, American journal of obstetrics and gynecology.

[66]  P. Bath,et al.  Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis , 2008, European heart journal.

[67]  L. Leeman,et al.  Venous thromboembolism during pregnancy. , 2008, American family physician.

[68]  P. Sandset,et al.  Ante‐ and postnatal risk factors of venous thrombosis: a hospital‐based case–control study , 2008, Journal of thrombosis and haemostasis : JTH.

[69]  F. Rosendaal,et al.  Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study , 2008, Journal of thrombosis and haemostasis : JTH.

[70]  T. Spencer,et al.  Progesterone and interferon tau regulate hypoxia-inducible factors in the endometrium of the ovine uterus. , 2008, Endocrinology.

[71]  B. Hunt,et al.  A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy , 2008, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[72]  M. Spannagl,et al.  Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women , 2007, Thrombosis and Haemostasis.

[73]  T. Krivak,et al.  Venous thromboembolism in obstetrics and gynecology. , 2007, Obstetrics and gynecology.

[74]  L. Hofmann,et al.  Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline , 2007, Annals of Internal Medicine.

[75]  G. Leone,et al.  The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis , 2006 .

[76]  E. Myers,et al.  Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. , 2006, American journal of obstetrics and gynecology.

[77]  K. Bailey,et al.  Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study , 2005, Annals of Internal Medicine.

[78]  T. Capstick,et al.  Efficacy of thrombolytic agents in the treatment of pulmonary embolism , 2005, European Respiratory Journal.

[79]  I. Greer,et al.  Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. , 2005, Blood.

[80]  S. Goldhaber,et al.  Thrombosis during pregnancy and the postpartum period. , 2005, American journal of obstetrics and gynecology.

[81]  A. Kaider,et al.  Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis , 2005, Journal of thrombosis and haemostasis : JTH.

[82]  S. Deitcher,et al.  Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. , 2004, Archives of internal medicine.

[83]  Giancarlo Agnelli,et al.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[84]  J. Hirsh,et al.  Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[85]  R. Zotz,et al.  Inherited thrombophilia and gestational venous thromboembolism. , 2003, Best practice & research. Clinical haematology.

[86]  K. Bremme.  Haemostatic changes in pregnancy. , 2003, Best practice & research. Clinical haematology.

[87]  C. Nelson-Piercy,et al.  Acquired thrombophilias and pregnancy. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[88]  A. Gori,et al.  Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[89]  Jeani Chang,et al.  Pregnancy-Related Mortality Surveillance — United States , 1991 – 1999 , 2003 .

[90]  J. Govert,et al.  Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. , 2002, Archives of internal medicine.

[91]  E. Taioli,et al.  Inherited Thrombophilia and First Venous Thromboembolism during Pregnancy and Puerperium , 2002, Thrombosis and Haemostasis.

[92]  Chien-Huang Lin,et al.  Mechanisms Involved in Agonist-Induced Hyperaggregability of Platelets from Normal Pregnancy , 2002, Journal of Biomedical Science.

[93]  R. Huch,et al.  Excretion of low molecular weight heparin in human milk. , 2001, British Journal of Clinical Pharmacology.

[94]  M. Petri.  Management of thrombosis in antiphospholipid antibody syndrome. , 2001, Rheumatic diseases clinics of North America.

[95]  R. Farmer,et al.  Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database , 2001, BJOG : an international journal of obstetrics and gynaecology.

[96]  J. Lavin,et al.  The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. , 2000, American journal of obstetrics and gynecology.

[97]  I. Greer.  Thrombosis in pregnancy: maternal and fetal issues , 1999, The Lancet.

[98]  R. Tait,et al.  Risk Factors for Pregnancy Associated Venous Thromboembolism , 1997, Thrombosis and Haemostasis.

[99]  A. Eastenson,et al.  Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? , 1997, The Journal of maternal-fetal medicine.

[100]  C. Berg,et al.  Pregnancy-related mortality surveillance--United States, 1987-1990. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[101]  P. Ridker,et al.  Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. , 1997, JAMA.

[102]  D. Ringrose.  Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients. , 1997, International journal of obstetric anesthesia.

[103]  O. Linder,et al.  The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.

[104]  I. Greer,et al.  An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy , 1997, British journal of obstetrics and gynaecology.

[105]  IngridPabinger,et al.  Thrombotic Risk in Hereditary Antithrombin III, Protein C, or Protein S Deficiency , 1996 .

[106]  G. Hughes,et al.  A study of sixty pregnancies in patients with the antiphospholipid syndrome. , 1996, Clinical and experimental rheumatology.

[107]  A. Goodall,et al.  Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. , 1994, Clinical science.

[108]  P. Brill-Edwards,et al.  Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation , 1992, Thrombosis and Haemostasis.

[109]  E. Gregory.  Nursing practice management: Karen, aged 15 years, has an above-the-knee amputation. , 1992, The Journal of school nursing : the official publication of the National Association of School Nurses.

[110]  G. Raskob,et al.  Serial impedance plethysmography in pregnant patients with clinically suspected deep‐vein thrombosis. Clinical validity of negative findings , 1990, Annals of internal medicine.

[111]  J. Gilabert,et al.  Plasminogen Activator Inhibitors Type 1 and Type 2 and Plasminogen Activators in Amniotic Fluid during Pregnancy , 1990, Thrombosis and Haemostasis.

[112]  G. Raskob,et al.  Serial Impedance Plethysmography in Pregnant Patients with Clinically Suspected Deep-Vein Thrombosis: Clinical Validity of Negative Findings , 1990 .

[113]  D. Gastineau,et al.  Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases , 1985, American journal of hematology.

[114]  H. Prydz,et al.  The coagulation factor VII in pregnancy , 1984, British journal of haematology.

[115]  R. V. Vande Wiele,et al.  Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. , 1975, The Journal of reproductive medicine.

[116]  Saumya Das,et al.  Expanding the horizon of EV-RNAs: LncRNAs in EVs as biomarkers for disease pathways , 2023, Extracellular vesicle.

[117]  C. Jain.  ACOG Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. , 2019, Obstetrics and gynecology.

[118]  Raouf A Khalil,et al.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. , 2017, Progress in molecular biology and translational science.

[119]  R. Zotz,et al.  Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH). , 2016, VASA. Zeitschrift fur Gefasskrankheiten.

[120]  L. González.  Pulmonary embolism in pregnancy. , 2014, Acute medicine.

[121]  H. Ranu,et al.  Thrombolysis for massive pulmonary embolism in pregnancy--a report of three cases and follow up over a two year period. , 2011, Thrombosis research.

[122]  A. James.  Pregnancy-associated thrombosis. , 2009, Hematology. American Society of Hematology. Education Program.

[123]  F. Spencer,et al.  Reading between the (Guidelines). Management of submassive pulmonary embolism in the first trimester of pregnancy. , 2008, Thrombosis research.

[124]  S. Bates.  Management of pregnant women with thrombophilia or a history of venous thromboembolism. , 2007, Hematology. American Society of Hematology. Education Program.

[125]  A. Le Querrec.  [Venous thromboembolism in pregnancy]. , 2003, La Revue du praticien.

[126]  M. Prins,et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. , 2000, The Cochrane database of systematic reviews.

[127]  C. Biron,et al.  Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study. , 1997, Fertility and sterility.

[128]  D. Branch.  Antiphospholipid antibodies and pregnancy: maternal implications. , 1990, Seminars in perinatology.

[129]  K. Lechner,et al.  Lupus Anticoagulants and Thrombosis , 1985 .

[130]  Pfeifer Gw.  Distribution and placental transfer of 131-I streptokinase. , 1970 .

[131]  G. Pfeifer.  Distribution and placental transfer of 131-I streptokinase. , 1970, Australasian annals of medicine.

[132]  C. P. Douglas.  Thromboembolic disease in pregnancy and the puerperium. , 1968, Midwife and health visitor.

[133]  K. Bestehorn,et al.  Vascular Health and Risk Management , 2022 .